European Archives - Page 2 of 1468 - European Medical Journal

The Age of Prevention: Interview with Eric Topol

I was really excited about cardiology when I was training in internal medicine, and it was a very extraordinary time, because this was….

WCO 2026 Interview: Noriko Yoshimura

I am deeply honoured to receive this award from IOF CSA. Looking back, I believe the most impactful aspect of my work has been…

Infant Nutrition and Lifelong Immunity

In this series, host Catherine Glass speaks with Meghan Azad about how early-life nutrition influences immune development from birth…..

Brain Histamine May Shape Mental Health Across the Lifespan

Brain Histamine May Shape Mental Health Across the Lifespan

A new study mapped the brain histamine system, revealing links with cognition, development, and psychiatric disorders.

79th World Health Assembly: Pandemic Risk Outpacing Investments

Pandemic risk is outpacing investments, an expert global monitoring group has warned in a new report launched on 18th May in the margins of the 79th World Health Assembly.

Dupilumab Shows Wider Benefits in Prurigo Nodularis - EMJ

Dupilumab Improves QoL in Prurigo Nodularis Patients

New trial data show dupilumab improves itch, skin healing and quality of life in patients with prurigo nodularis, even without optimal response.

PrEP Uptake in France Slows HIV Prevention Progress - EMJ

Low PrEP Uptake Slows France’s HIV Prevention Goals

France’s HIV prevention efforts are hindered by low PrEP uptake, especially among women, migrants and younger people despite full health system reimbursement.

Venetoclax Regimen Improves Survival in Older AML Patients

A venetoclax-based AML regimen produced high remission rates and prolonged survival in older or unfit patients with newly diagnosed acute myeloid leukaemia.

Metabolomic Profiling Reveals Hidden Asthma Disease Subtypes

Metabolomic profiling identified distinct biological asthma subgroups despite similar symptom control and exacerbation histories.

Survival Gains in Pancreatic Cancer with Daraxonrasib

Daraxonrasib demonstrated encouraging survival and tumour response outcomes in advanced pancreatic cancer trials.